Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Vertex Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€158.36
17.06.21
€165.00
17.06.22
59.60%
18.06.22

Could be worthwhile Investment >10% per year
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€32.84
17.05.21
€37.00
17.05.22
47.77%
18.05.22

buy
Kadmon Holdings LLC

Start price
Target price
Perf. (%)
€3.12
17.05.21
€4.00
17.05.22
162.71%
18.05.22

buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€32.70
09.05.21
€35.00
09.05.22
40.49%
10.05.22

buy
Zosano Pharma Corp.

Start price
Target price
Perf. (%)
€1.43
02.05.22
€1.00
02.05.23
18.02%
05.05.22

Could be worthwhile Investment >10% per year
Capable Management
Good culture
Growths slower than the competition
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€29.88
21.03.21
€35.00
21.03.22
64.07%
22.03.22

buy
Aveo Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€3.64
09.01.22
€4.00
09.01.23
37.21%
21.03.22

buy
Avenue Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.015
20.02.22
€7.50
20.03.22
61900.00%
21.03.22

Could be worthwhile Investment >10% per year
buy
AbbVie Inc.

Start price
Target price
Perf. (%)
€115.90
16.12.21
€120.00
16.03.22
23.37%
16.03.22

buy
Chemocentryx Inc.

Start price
Target price
Perf. (%)
€11.37
17.06.21
€18.00
09.03.22
95.60%
10.03.22

Could be very worthwhile Investment >20% year
buy
Epizyme Inc.

Start price
Target price
Perf. (%)
€1.10
27.01.22
€1.00
27.01.23
41.00%
05.02.22

Could be worthwhile Investment >10% per year
Capable Management
Bad culture
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€463.95
25.01.21
€500.00
25.01.22
15.42%
26.01.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€132.40
14.01.21
€144.00
14.01.22
10.89%
15.01.22

buy
Catalyst Pharmaceutical Partners Inc

Start price
Target price
Perf. (%)
€2.84
05.01.21
€3.50
05.01.22
100.71%
06.01.22

buy
Intellia Therapeutics Inc

Start price
Target price
Perf. (%)
€46.03
04.01.21
€60.00
04.01.22
115.51%
05.01.22

buy
Zoetis Inc. A

Start price
Target price
Perf. (%)
€137.00
03.01.21
€150.00
03.01.22
50.37%
04.01.22

buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€125.32
28.12.20
€140.00
28.12.21
20.17%
29.12.21

buy
MannKind Corp.

Start price
Target price
Perf. (%)
€2.99
16.12.20
€3.50
16.12.21
20.27%
17.12.21

Biogen Inc.

Start price
Target price
Perf. (%)
€243.10
18.10.21
€210.00
02.01.23
-12.53%
16.12.21

Could be worthwhile Investment >10% per year
buy
Amphastar Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€15.30
15.12.20
€18.00
15.12.21
28.10%
16.12.21

buy
Dare Bioscience Inc.

Start price
Target price
Perf. (%)
€1.06
13.12.20
€1.20
13.12.21
47.17%
14.12.21

buy
Ardelyx Inc.

Start price
Target price
Perf. (%)
€0.99
30.11.21
€1.00
30.11.22
36.36%
11.12.21

Could be very worthwhile Investment >20% year
Good culture
Innovative
Few uniques
buy
Avid Bioservices Inc

Start price
Target price
Perf. (%)
€8.05
03.12.20
€9.00
03.12.21
200.62%
04.12.21

Invitae Corp

Start price
Target price
Perf. (%)
€20.09
09.11.21
€17.00
31.12.23
-23.92%
01.12.21

Could be very worthwhile Investment >20% year
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€442.80
23.11.20
€555.00
23.11.21
29.97%
24.11.21

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Standard Investments for future growth